Live Quote · NASDAQAPREHealthcare· Biotechnology

Aprea Therapeutics, Inc.

$0.23▼ 53.56%($-0.26)
MKT CAP $3.25MNEXT EARNINGS Mar 15, 2027
50%
Bullish
TickerSpark Score
57/100
▌ Mixed
100
Valuation
20
Profitability
50
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APRE research report →

Analyst RatingBuy
4 Buy2 Hold2 Sell

Price Chart

-79.37% · this period
$1.26$0.74$0.23Nov 20May 26Nov 20
52-Week Range2% of range
Low
$0.20
Current
$0.23
High
$1.49